Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma

Journal of Clinical Oncology

Volumn 27, Issue 4, 2009, Pages 566-571

  Gandola, Lorenza ^a   Massimino, Maura ^a   Cefalo, Graziella ^a   Solero, Carlo ^a   Spreafico, Filippo ^a   Pecori, Emilia ^a   Riva, Daria ^a   Collini, Paola ^a   Pignoli, Emanuele ^a   Giangaspero, Felice ^a   Luksch, Roberto ^a   Berretta, Serena ^a   Poggi, Geraldina ^a   Biassoni, Veronica ^a   Ferrari, Andrea ^a   Pollo, Bianca ^a   Favre, Claudio ^a   Sardi, Iacopo ^a   Terenziani, Monica ^a   Fossati Bellani, Franca ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LOMUSTINE; METHOTREXATE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BLOOD TOXICITY; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG MEGADOSE; DRUG RESPONSE; ENCEPHALITIS; ERYTHROCYTE TRANSFUSION; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HYPERFRACTIONATED ACCELERATED RADIOTHERAPY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDULLOBLASTOMA; METASTASIS; OVERALL SURVIVAL; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS INFECTION; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; SEPSIS; SHUNT INFECTION; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 59149102350     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.4176     Document Type: Article

References (36)

1. Michalski AG, Garrè ML: Infant brain tumours, in Walker D, Perilongo G, Punt JAG, et al (eds): Brain and Spinal Tumours of Childhood. London, United Kingdom, 2004, pp 359-369
2. Vogel H, Fuller GN: Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems. Ann Diagn Pathol 7:387-398, 2003
3. Rutkowski S, von Bueren A, von Hoff K, et al: Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: Results of patients treated in the prospective multicenter trial HIT'91. Clin Cancer Res 13:2651-2657, 2007
4. Rutkowski S, Bode U, Deinlein F, et al: Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978-986, 2005
5. Packer RJ, Rood BR, MacDonald TJ: Medulloblastoma: Present concepts of stratification into risk groups. Pediatr Neurosurg 39:60-67, 2003
6. Zeltzer PM, Boyett JM, Finlay JL, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845, 1999
7. Gajjar A, Chintagumpala M, Ashley D, et al: Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 7:813-820, 2006
8. Chang CH, Housepian EM, Herbert C Jr: An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastomas. Radiology 93:1351-1359, 1969
9. Shih CS, Hale GA, Gronewold L, et al: High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors. Cancer 112:1345-1353, 2008
10. Pignoli E, Gandola L, Somigliana A, et al: Optimization of the irradiation technique for children with medulloblastoma (MBL): European Society for Therapeutic Radiology and Oncology, ESTRO 17th Annual Meeting, Edinburg, Scotland, UK, 20-24 September, 1998. Radiother Oncol 48:S209, 1998 (suppl 1; abstr 822)
11. Massimino M, Gandola L, Luksch R, et al: Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell (CPC) rescue, and radiotherapy for childhood high-grade glioma. Neuro-oncol 7:41-48, 2005
12. Gnekow AC: Recommendations of the Brain Tumor Subcommittee for the reporting of trials: SIOP Brain Tumor Subcommittee - International Society of Pediatric Oncology. Med Pediatr Oncol 24:104-108, 1995
13. Kaplan EL, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481, 1958
14. Peto R, Peto J: Asymptomatically efficient rank invariant test procedures. J R Stat Soc A 135:185-207, 1972
15. Cox R: Regression models and life tables. J R Stat Soc B 34:187-202, 1972
16. Mazza E, Spreafico F, Cefalo G, Scaramuzza D, Massimino M: Case report: Pseudomonas aeruginosa-related intervertebral discitis in a young boy with medulloblastoma. J Neurooncol 68:245-248, 2004
17. Spreafico F, Gandola L, Marchianò A, et al: Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors. Int J Radiat Oncol Biol Phys 70:1011-1019, 2008
18. Tait DM, Thornton-Jones H, Bloom HJ, et al: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464-469, 1990
19. Evans AE, Jenkin RD, Sposto R, et al: The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582, 1990
20. Packer RJ, Siegel KR, Sutton LN, et al: Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: A preliminary report. Ann Neurol 24:503-508, 1988
21. Verlooy J, Mosseri V, Bracard S, et al: Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study. Eur J Cancer 42:3004-3014, 2006
22. Kortmann RD, Kuhl J, Timmermann B, et al: Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46:269-279, 2000
23. Strother D, Ashley D, Kellie SJ, et al: Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: Results of a collaborative study. J Clin Oncol 19:2696-2704, 2001
24. Chi SN, Gardner SL, Levy AS, et al: Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 22:4881-4887, 2004
25. Kovnar EH, Kellie SJ, Horowitz ME: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: A phase II study. J Clin Oncol 8:330-336, 1990
26. Heideman RL, Kovnar EH, Kellie SJ, et al: Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. J Clin Oncol 13:2247-2254, 1995
27. Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55:749-756, 1981
28. Jakacki RI: Treatment strategies for high-risk medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurosurg 102:44-52, 2005
29. Prados MD, Edwards MS, Chang SM, et al: Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Results of a Phase II study. Int J Radiat Oncol Biol Phys 43:279-285, 1999
30. Allen JC, Donahue B, DaRosso R, et al: Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int J Radiat Oncol Biol Phys 36:1155-1161, 1996
31. Marymont MH, Geohas J, Tomita T, et al: Hyperfractionated craniospinal radiation in medulloblastoma. Pediatr Neurosurg 24:178-184, 1996
32. Wheldon TE, O'Donoghue JA, Barret A: Kinetic considerations in the choice of treatment schedules for neuraxis radiotherapy. Br J Radiol 66:61-66, 1993
33. Ito S, Hoshino T, Prados MD, et al: Cell kinetics of medulloblastoma. Cancer 70:671-678, 1992
34. del Charco JO, Bolek TW, McCollough WM, et al: Medulloblastoma: Time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys 42:147-154, 1998
35. Dale RG: Time-dependent tumour repopulation factors in linear-quadratic equations: Implications for treatment strategies. Radiother Oncol 15:371-381, 1989
36. Castelli E, Poggi G, Massimino M, et al: Outcome and quality of life after medulloblastoma treatment in children: International Society of Paediatric Oncology SIOP XXXV Meeting Cairo, Egypt October 8-11, 2003. Med Pediatr Oncol 41:292, 2003 (abstr O143)